These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 27149811)

  • 41. [Mineral metabolism in patients on chronic peritoneal dialysis].
    Ceballos O ML; Rojo L A; Azócar P M; Ibacache M MJ; Delucchi B A; Quiroz Z L; Irarrázabal M C; Delgado B I; Ugarte P F; Cano Sch F
    Rev Chil Pediatr; 2014 Feb; 85(1):31-9. PubMed ID: 25079181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.
    Seiler S; Rogacev KS; Roth HJ; Shafein P; Emrich I; Neuhaus S; Floege J; Fliser D; Heine GH
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1049-58. PubMed ID: 24677555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between circulating FGF23, α-Klotho, and left ventricular diastolic dysfunction among patients with preserved ejection fraction.
    Okamoto Y; Fujita S; Morita H; Kizawa S; Ito T; Sakane K; Sohmiya K; Hoshiga M; Ishizaka N
    Heart Vessels; 2016 Jan; 31(1):66-73. PubMed ID: 25223536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in FGF-23, Neutrophil/Platelet Activation Markers, and Angiogenin in Advanced Chronic Kidney Disease and Their Effect on Arterial Stiffness.
    Choi HM; Kwon YE; Kim S; Oh DJ
    Kidney Blood Press Res; 2019; 44(5):1166-1178. PubMed ID: 31553973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease].
    Dzgoeva FU; Gatagonova TM; Bestaeva TL; Sopoev MIu; Bazaeva BG; Khamitsaeva OV
    Ter Arkh; 2014; 86(6):63-9. PubMed ID: 25095658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New Insights into the Role of FGF-23 and Klotho in Cardiovascular Disease in Chronic Kidney Disease Patients.
    Memmos E; Papagianni A
    Curr Vasc Pharmacol; 2021; 19(1):55-62. PubMed ID: 32310050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paricalcitol regulatory effect on inflammatory, fibrotic and anticalcificating parameters in renal patiente. Far beyond mineral bone disease regulation.
    Salanova Villanueva L; Gil Giraldo Y; Santos Sánchez-Rey B; Aguilera Peralta A
    Nefrologia (Engl Ed); 2020; 40(2):171-179. PubMed ID: 31740151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardio-ankle vascular index is linked to deranged metabolic status, especially high HbA1c and monocyte-chemoattractant-1 protein, in predialysis chronic kidney disease.
    Mert M; Dursun B; Yağcı AB; Çetin Kardeşler A; Şenol H; Demir S
    Int Urol Nephrol; 2020 Jan; 52(1):137-145. PubMed ID: 31773386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease.
    Ribeiro AL; Mendes F; Carias E; Rato F; Santos N; Neves PL; Silva AP
    J Diabetes Complications; 2020 Jan; 34(1):107476. PubMed ID: 31708378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FGF23 and Klotho in relation to markers of endothelial dysfunction in kidney transplant recipients.
    Malyszko J; Koc-Zorawska E; Matuszkiewicz-Rowinska J; Malyszko J
    Transplant Proc; 2014 Oct; 46(8):2647-50. PubMed ID: 25380886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients.
    Turan MN; Kircelli F; Yaprak M; Sisman AR; Gungor O; Bayraktaroglu S; Ozkahya M; Asci G; Floege J; Ok E
    Int Urol Nephrol; 2016 Apr; 48(4):609-17. PubMed ID: 26865177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation.
    Eser B; Yayar O; Buyukbakkal M; Erdogan B; Ercan Z; Merhametsiz O; Haspulat A; Oğuz EG; Dogan İ; Canbakan B; Ayli MD
    Nefrologia; 2015; 35(5):465-72. PubMed ID: 26394828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomarkers of kidney injury and klotho in patients with atherosclerotic renovascular disease.
    Park MY; Herrmann SM; Saad A; Eirin A; Tang H; Lerman A; Textor SC; Lerman LO
    Clin J Am Soc Nephrol; 2015 Mar; 10(3):443-51. PubMed ID: 25542906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gender Specific Association between Serum Fibroblast Growth Factor 23/α-Klotho and Coronary Artery and Aortic Valve Calcification.
    Morita H; Takeda Y; Fujita S; Okamoto Y; Sakane K; Teramoto K; Ozeki M; Tasaki R; Kizawa S; Sohmiya K; Hoshiga M; Ishizaka N
    J Atheroscler Thromb; 2015; 22(12):1338-46. PubMed ID: 26279337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in Serum Concentrations of Fibroblast Growth Factor 23 and Soluble Klotho in Hemodialysis Patients after Total Parathyroidectomy.
    Liao SC; Moi SH; Chou FF; Yang CH; Chen JB
    Biomed Res Int; 2016; 2016():6453803. PubMed ID: 27999806
    [No Abstract]   [Full Text] [Related]  

  • 57. Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trial.
    Bergmark BA; Udell JA; Morrow DA; Jarolim P; Kuder JF; Solomon SD; Pfeffer MA; Braunwald E; Sabatine MS
    Eur J Heart Fail; 2019 Apr; 21(4):462-470. PubMed ID: 30773798
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating Klotho Associates With Cardiovascular Morbidity and Mortality During Hemodialysis.
    Marçais C; Maucort-Boulch D; Drai J; Dantony E; Carlier MC; Blond E; Genet L; Kuentz F; Lataillade D; Legrand E; Moreau-Gaudry X; Jean G; Fouque D;
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3154-3161. PubMed ID: 28402487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
    Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J
    Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.
    Lim K; Lu TS; Molostvov G; Lee C; Lam FT; Zehnder D; Hsiao LL
    Circulation; 2012 May; 125(18):2243-55. PubMed ID: 22492635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.